目的 比较多种油脂肪乳剂(multi-oil fat emulsion,SMOFlipid)和大豆油脂肪乳剂(soybean oil-fat emulsion,Intralipid)分别应用于极低出生体重儿(very low birth weight infants,VLBW)肠外营养的安全性。方法 通过回顾性病历数据研究,选取我院2016年至2022年新生儿科收治的VLBW为研究对象,根据纳入标准和排除标准,比较Intralipid 组和SMOFlipid组VLBW的临床特征、临床并发症及相关治疗结局。结果 共有273例VLBW被纳入研究,Intralipid组117例,SMOFlipid组156例。两组研究对象在出生胎龄、性别和体重等方面相似。SMOFlipid与较短的住院时间相关(68 d vs. 81 d,P<0.001)。SMOFlipid组的视网膜疾病发病率较低(31.4% vs. 46.2%,P=0.013),但多因素回归分析表明差异无统计学意义(OR 0.557,95%CI[0.287, 1.082];P=0.084)。两组VLBW在死亡率、胆汁淤积症发生率和支气管肺发育不良等其他疾病发生率方面差异无统计学意义。结论 与Intralipid相比,SMOFlipid在VLBW群体中具有相似的安全性。
Abstract
OBJECTIVE To compare the safety of multi-oil fat emulsion (SMOFlipid) and soybean oil-fat emulsion (Intralipid) in parenteral nutrition of very low birth weight infants (VLBW), respectively. METHODS Through retrospective medical record data study, the VLBW admitted to the neonatal department of our hospital from 2016 to 2022 were selected as the research objects. According to the inclusion and exclusion criteria, the clinical characteristics, clinical complications and related outcomes of VLBW in the Intralipid group and the SMOFlipid group were compared. RESULTS A total of 273 VLBW patients were included in the study, 117 in the Intralipid group and 156 in the SMOFlipid group. The two groups were similar in terms of gestational age at birth, sex and weight. SMOFlipid was associated with shorter hospital stay (68 d vs. 81 d, P＜0.001). The incidence of retinopathy of prematurity was lower in the SMOFlipid group (31.4% vs. 46.2%, P=0.013), but multivariate regression analysis showed no statistical difference (OR 0.557,95% CI[0.287, 1.082], P=0.084). There were no statistically significant differences in mortality, cholestasis, and other diseases such as bronchopulmonary dysplasia between the two VLBW groups. CONCLUSIONS Compared with Intralipid, SMOFlipid has a similar safety profile in the VLBW population.
关键词
肠外营养 /
极低出生体重儿 /
脂肪乳剂
{{custom_keyword}} /
Key words
parenteral nutrition /
extremely low birth weight infant /
lipid emulsion
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] FRAZER L C, MARTIN C R. Parenteral lipid emulsions in the preterm infant: current issues and controversies [J]. Arch Dis Child Fetal Neonatal Ed, 2021, 106(6):676-681.
[2] LAPILLONNE A, FIDLER MIS N, GOULET O, et al. ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids [J]. Clin Nutr, 2018, 37(6 Pt B):2324-2336.
[3] MIRTALLO J M, DASTA J F, KLEINSCHMIDT K C, et al. State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications [J]. Ann Pharmacother, 2010, 44(4):688-700.
[4] CHOUDHARY N, TAN K, MALHOTRA A. Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study [J]. Eur J Pediatr, 2018, 177(5):723-731.
[5] HILL N S, CORMACK B E, LITTLE B S, et al. Growth and clinical outcome in very low-birth-weight infants after the introduction of a multicomponent intravenous lipid emulsion [J]. J Parenter Enteral Nutr, 2020, 44(7):1318-1327.
[6] REN T, CONG L, WANG Y, et al. Lipid emulsions in parenteral nutrition: current applications and future developments [J]. Expert Opin Drug Deliv, 2013, 10(11):1533-1549.
[7] SKOUROLIAKOU M, KONSTANTINOU D, AGAKIDIS C, et al. Parenteral MCT/omega-3 poly-unsaturated fatty acid-enriched intravenous fat emulsion is associated with cytokine and fatty acid profiles consistent with attenuated inflammatory response in preterm neonates: a randomized, double-blind clinical trial [J]. Nutr Clin Pract, 2016, 31(2):235-244.
[8] GUTHRIE G, TACKETT B, STOLL B, et al. Phytosterols synergize with endotoxin to augment inflammation in kupffer cells but alone have limited direct effect on hepatocytes [J]. J Parenter Enteral Nutr, 2018, 42(1):37-48.
[9] GUTHRIE G, BURRIN D. Impact of parenteral lipid emulsion components on cholestatic liver disease in neonates [J]. Nutrients, 2021, 13(2):508. DOI: 10.3390/nu13020508.
[10] DESHPANDE G C, CAI W. Use of lipids in neonates requiring parenteral nutrition [J]. J Parenter Enteral Nutr, 2020, 44(1):S45-S54.
[11] CHEN I L, HUNG C H, HUANG H C. Smoflipid is better than lipofundin for long-term neurodevelopmental outcomes in preterm infants [J]. Nutrients, 2021, 13(8):2548. DOI: 10.3390/nu13082548.
[12] RAY S. NICE guideline review: Neonatal parenteral nutrition (NG154) [J]. Arch Dis Child Educ Pract Ed, 2021, 106(5):292-295.
[13] RAPTIS D A, LIMANI P, JANG J H, et al. GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids [J]. J Hepatol, 2014, 60(3):625-632.
[14] CARTER B A, TAYLOR O A, PRENDERGAST D R, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR [J]. Pediatr Res, 2007, 62(3):301-306.
[15] XU Z, HARVEY K A, PAVLINA T, et al. Steroidal compounds in commercial parenteral lipid emulsions [J]. Nutrients, 2012, 4(8):904-921.
[16] BELZA C, WALES J C, GLENDA C M, et al. An observational study of Smoflipid vs Intralipid on the evolution of intestinal failur-associated liver disease in infants with intestinal failure [J]. J Parenter Enteral Nutr, 2020, 44(4):688-696.
[17] TORGALKAR R, DAVE S, SHAH J, et al. Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: a pre-post comparative study [J]. J Perinatol, 2019, 39(8):1118-1124.
[18] TOMITA Y, USUI-OUCHI A, NILSSON A K, et al. Metabolism in retinopathy of prematurity [J]. Life (Basel), 2021, 11(11):1119. DOI: 10.3390/life11111119.
[19] LOFQVIST C A, NAJM S, HELLGREN G, et al. Association of retinopathy of prematurity with low levels of arachidonic acid: a secondary analysis of a randomized clinical trial [J]. JAMA Ophthalmol, 2018, 136(3):271-277.
[20] FU Z, LOFQVIST C A, SHAO Z, et al. Dietary omega-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin [J]. Am J Clin Nutr, 2015, 101(4):879-888.
[21] FU Z, LOFQVIST C A, SHAO Z, et al. Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin[J]. Am J Clin Nutr, 2015, 101(4):879-888.
[22] TORGALKAR R, DAVE S, SHAH J, et al. Multi-component lipid emulsion vs. soy-based lipid emulsion for very low birth weight preterm infants: a pre-post comparative study [J]. J Perinatol, 2019, 39(8):1118-1124.
[23] STRAMARA L, HERNANDEZ L, BLOOM B T, et al. Development of parenteral nutrition-associated liver disease and other adverse effects in infants receiving SMOFlipid or Intralipid [J]. J Parenter Enteral Nutr, 2020, 44(8):1530-1534.
[24] HELLSTRÖM A, PIVODIC A, GRÄNSE L, et al. Association of docosahexaenoic acid and arachidonic acid serum levels with retinopathy of prematurity in preterm infants [J]. JAMA Netw Open, 2021, 4(10):e2128771. DOI: 10.1001/jamanetworkopen.2021.28771.
[25] HELLSTRÖM A, NILSSON AK, WACKERNAGEL D, et al. Effect of enteral lipid supplement on severe retinopathy of prematurity: a randomized clinical trial [J]. JAMA Pediatr, 2021, 175(4):359-367.
[26] HSIAO C C, CHANG J C, TSAO L Y, et al. Correlates of elevated interleukin-6 and 8-hydroxy-2'-deoxyguanosine levels in tracheal aspirates from very low birth weight infants who develop bronchopulmonary dysplasia [J]. Pediatr Neonatol, 2017, 58(1):63-69.
[27] BERNHARD W, RAITH M, KOCH V, et al. Developmental changes in polyunsaturated fetal plasma phos-pholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia [J]. Eur J Nutr, 2016, 55(7):2265-7224.
[28] GUTHRIE G, PREMKUMAR M, BURRIN D G. Emerging clinical benefits of new-generation fat emulsions in preterm neonates [J]. Nutr Clin Pract, 2017, 32(3):326-336.
[29] HSIAO C C, LIN H C, CHANG Y J, et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: a double-blind, randomized controlled trial [J]. Clin Nutr, 2019, 38(3):1045-1052.
[30] XUE FAN, YING TANG, JUN TANG, et al. New-generation intravenous fat emulsions and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis [J]. J Perinatol, 2020, 40(11):1585-1596.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
浙江省自然基金项目资助(LYY19H300002);浙江省医学会临床科研基金项目资助(2020ZYC-A411);杭州市医药卫生科技项目资助(A20200682)
{{custom_fund}}
PDF(938 KB)
